Product Information
QC MUCUS RLF MAX 400-20 MG/20 ML is a generic product labeled by Chain Drug Marketing Association, priced at $0.0212 per ML under NDC 83324002606. Its NADAC has been published 96 times since Dec 4, 2024.
Strength
20; 400 mg/20mL; mg/20mL
Manufacturer
Chain Drug Marketing AssociationNDC
83324002606
Classification
Generic
Dosage Form
LIQUID
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESINApproval Type
OTC MONOGRAPH DRUG
FDA Application
part341On Market Since
4/26/2024
Pharmacological Classes
Price Statistics
The NADAC for QC MUCUS RLF MAX 400-20 MG/20 ML has been published 96 times since Dec 4, 2024, and over the history we have for it it has risen 4.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0212 per ML |
|---|---|
| All-time high | $0.0217 (May 13, 2026) |
| All-time low | $0.0203 (Dec 4, 2024) |
| 52-week high | $0.0217 |
| 52-week low | $0.0211 |
| Median price | $0.0212 |
| Average price | $0.0212 |
| Largest weekly change | +1.7% (Jan 22, 2025) |
| Weeks tracked | 96 |
| Tracking since | Dec 4, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Dextromethorphan HBr, Guaifenesin market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Chain Drug Marketing Association manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Dextromethorphan HBr, Guaifenesin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Expectorant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of QC MUCUS RLF MAX 400-20 MG/20 ML?
The current National Average Drug Acquisition Cost (NADAC) for QC MUCUS RLF MAX 400-20 MG/20 ML, manufactured by Chain Drug Marketing Association, is $0.0212 per ML (NDC 83324002606), effective Sep 30, 2026.
How has the price of QC MUCUS RLF MAX 400-20 MG/20 ML changed over time?
Over the history we have for it, the NADAC for QC MUCUS RLF MAX 400-20 MG/20 ML has risen 4.7%. It has been tracked across 96 weekly CMS publications since Dec 4, 2024.
What are the highest and lowest recorded NADAC prices for QC MUCUS RLF MAX 400-20 MG/20 ML?
Since Dec 4, 2024, the NADAC for QC MUCUS RLF MAX 400-20 MG/20 ML has ranged from a low of $0.0203 (Dec 4, 2024) to a high of $0.0217 (May 13, 2026), with a median of $0.0212 per ML.
Are there cheaper alternatives to QC MUCUS RLF MAX 400-20 MG/20 ML?
No other NADAC-published product currently shares the active ingredient and strength of QC MUCUS RLF MAX 400-20 MG/20 ML in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures QC MUCUS RLF MAX 400-20 MG/20 ML?
QC MUCUS RLF MAX 400-20 MG/20 ML (NDC 83324002606) is labeled by Chain Drug Marketing Association, and CMS classifies it as a generic product.